FY23 Corporate Strategy and Sustainability Journey slide image

FY23 Corporate Strategy and Sustainability Journey

We are doubling down on our innovative work on cancer with the mission of conquering cancer through our subsidiary Aurigene Oncology • • • 350+ Scientists 200+ 80+ Discovery NCE patents projects 19+ Under 20+ Years of clinical devp. exp. Aurigene Oncology Conquering Cancer Our focus - To discover & develop therapeutics to improve lives of cancer patients • Contributed to deliver 19 novel chemical entities for clinical development Out-licensed several first/best-in-class compounds Recently established capabilities in anti-body drug discovery and Cell & Gene Therapy Healthy product pipeline in discovery and clinical development We have under development a proprietary product pipeline of 15 programs - ⚫ Clinical stage - 8 programs IND stage-2 programs Lead optimization stage - 5 programs • In addition, we have 11 partnered programs under clinical stage 21 copyright Dr. Reddy's Ltd.
View entire presentation